05-Dec-14 India produces a third of the world's medicines, mostly in the form of generic drugs. But more than 80% of the raw materials for these drugs are imported from China. That gives its neighbour a virtual monopoly over pricing and supply - so much so that there are now no domestic Indian producers of many essential medicines, a situation that worries the Indian government. [image: The Insider]

04-Dec-14 GE Healthcare Life Sciences is planning to open a Technology Laboratory in Turkey which will feature the company’s latest tools for drug discovery, protein science and bioprocessing research. Turkey plans to transform its domestic manufacturing of devices and pharmaceuticals, with plans for 60% of demand to be met locally. [image: GE Healthcare Life Sciences]

01-Dec-14 The top 20 pharmaceutical companies are developing 327 products for developing countries - yet only five of them account for more than half of these: Novartis, Johnson & Johnson, GSK, AbbVie and Sanofi. [image: Access to medicine index]

26-Nov-14 China plans to scrap retail price caps on all drugs as early as the start of 2015, giving market forces a larger role in an industry where price controls have contributed to supply shortages. A recent crackdown on high prices pushed some Chinese firms out of business and forced global drug-makers to rethink their China strategy. [image: My Jungle Blog]

23-Nov-14 A Chinese health official has said that Traditional Chinese Medicine (TCM) will take a bigger role in medical reform in future as it has certain advantages in both prevention and care. In 2013, China’s TCM output was over USD91 billion, one third of the country’s medicine industry. [image: China Daily Europe]